AngioDynamics, Inc. has grown revenue −1.1% a year over three years and 1.8% a year over five. Revenue growth, 3-year annual rate: −1.1% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +1.8%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2010 to FY2026, as filed.

ANGOAngioDynamics, Inc.

Healthcare

$11.22+1.5% 1Y

$11.22

$9.7052 weeks$16.12

Latest close: below its 200-day averageOct 8, 2026what changed →

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+1.3 points).

1 good, 1 neutral, 1 without data

Revenue trend+8% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +2% a year.

Margin direction+1.3 points operating

Trailing-twelve-month operating margin, -11.3% now against -12.6% a year earlier.

All from SEC EDGAR, as of Aug 31, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ANGO growing?

AngioDynamics, Inc. has grown revenue −1.1% a year over three years and 1.8% a year over five.

−1.1%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +1.8%
Revenue growth, 5-year rate · −1.1% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2010 to FY2026, as filed

Details›